advanc
new
vaccin
base
live
viral
vector
requir
sensit
assay
analyz
vivo
replic
gene
express
genet
stabil
studi
attenu
canin
distemp
viru
cdv
use
vaccin
deliveri
vector
duplex
quantit
realtim
rtpcr
rtqpcr
assay
specif
genom
rna
grna
mrna
develop
concurr
quantifi
code
sequenc
cdv
nucleocapsid
protein
n
foreign
vaccin
antigen
siv
gag
amplicon
detect
limit
copi
per
pcr
reaction
use
show
abdomin
caviti
lymphoid
tissu
primari
site
cdv
vector
replic
infect
ferret
importantli
cdv
grna
mrna
undetect
brain
tissu
addit
grna
duplex
assay
adapt
monitor
foreign
gene
insert
genet
stabil
vivo
replic
analyz
ratio
cdv
n
siv
gag
genom
rna
copi
cours
vector
infect
measur
found
sensit
probe
assess
vivo
genet
stabil
foreign
gene
insert
canin
distemp
viru
cdv
member
paramyxovirida
famili
morbilliviru
genu
accordingli
envelop
viru
singlestrand
nonseg
negativesens
rna
genom
genom
contain
six
gene
region
organ
encod
eight
known
viral
polypeptid
mcilhatton
et
al
cdv
relat
measl
viru
mev
caus
system
diseas
domest
wild
dog
fox
wolv
cdv
outbreak
also
occur
among
small
carnivor
includ
mink
ferret
trebbien
et
al
viru
link
diseas
lion
tiger
seal
harder
osterhau
natur
infect
canin
lead
central
nervou
system
diseas
experiment
infect
ferret
cdv
strain
also
result
neuroinvas
neurovirul
intranas
inocul
langloi
rudd
et
al
recent
report
measleslik
ill
macaqu
coloni
attribut
cdv
qiu
et
al
sakai
et
al
sun
et
al
experiment
infect
nonhuman
primat
studi
recent
de
vri
et
al
although
cdv
infect
link
convincingli
human
diseas
rima
duprex
live
attenu
cdv
vaccin
effect
safe
control
diseas
domest
dog
popul
chappui
paramyxovirus
attract
vaccin
vector
varieti
reason
notabl
system
exist
genet
manipul
deliv
mucos
case
live
attenu
vaccin
virus
avail
use
foundat
vaccin
deliveri
vector
billet
et
al
bukreyev
et
al
exampl
attenu
mev
strain
use
develop
experiment
vaccin
vector
express
antigen
hepat
b
viru
del
vall
et
al
singh
et
al
hiv
siv
brandler
tangi
lorin
et
al
tangi
naim
zuniga
et
al
west
nile
viru
despr
et
al
dengu
viru
brandler
et
al
sarscoronaviru
linig
et
al
hepat
c
viru
satoh
et
al
although
mev
attract
vector
candid
long
track
record
use
human
preexist
neutral
immun
mev
might
limit
use
sinc
recombin
cdv
rcdv
express
foreign
protein
ludlow
et
al
park
et
al
von
messl
et
al
wang
et
al
attenu
cdv
vector
encod
siv
immunogen
develop
evalu
whether
might
provid
safe
altern
mev
advanc
hiv
vaccin
candid
less
subject
preexist
antimev
antibodi
zhang
et
al
evalu
cdv
replic
gene
express
host
anim
sensit
assay
requir
detect
quantifi
viru
specimen
typic
infecti
cdv
quantifi
plaqu
assay
suscept
cell
monolay
bussel
karzon
routin
diagnost
test
conduct
immunofluoresc
appel
serolog
method
enzymelink
immunosorb
elisa
seroneutr
assay
frisk
et
al
gemma
et
al
von
messl
et
al
viru
isol
canin
cell
frisk
et
al
kim
et
al
shin
et
al
sensit
assay
viru
isol
show
cytopath
effect
earli
h
sampl
inocul
develop
base
vero
cell
express
canin
signal
lymphocyt
activ
molecul
seki
et
al
assay
though
proven
use
time
consum
requir
sever
day
week
obtain
result
recent
sever
rtpcr
nest
pcr
base
assay
develop
diagnosi
cdv
nucleocapsid
protein
rna
cerebrospin
fluid
nasal
swab
peripher
blood
mononuclear
cell
saliva
serum
urin
whole
blood
dog
frisk
et
al
kim
et
al
rzezutka
mizak
saito
et
al
shin
et
al
von
messl
et
al
assay
sensit
sensit
vari
sampl
sourc
viral
rna
extract
method
choic
primer
recent
quantit
realtim
pcr
qpcr
revers
transcriptionqpcr
rtqpcr
assay
develop
detect
cdv
elia
et
al
fischer
et
al
meli
et
al
pawar
et
al
scagliarini
et
al
wilk
et
al
mani
virus
includ
rabi
viru
hugh
et
al
bluetongu
viru
toussaint
et
al
siv
cline
et
al
vesicular
stomat
viru
vsv
assay
valuabl
provid
estim
viral
load
plasma
infect
tissu
organ
anim
report
develop
character
rtqpcr
assay
describ
use
evalu
rcdv
rcdv
vector
encod
siv
gag
singleplex
rtqpcr
assay
optim
specif
detect
essenti
cdv
gene
cdv
n
foreign
siv
gag
insert
sequenc
grna
mrna
duplex
rtqpcr
assay
develop
detect
simultan
cdv
n
siv
gag
grna
mrna
homogen
tissu
specimen
ferret
inocul
cdv
vector
encod
gag
vector
lack
insert
assay
enabl
rapid
reliabl
sensit
detect
cdv
n
siv
gag
use
compil
vivo
data
replic
distribut
genet
stabil
earli
prototyp
rcdvsivgag
vector
importantli
use
grna
duplex
assay
monitor
rel
quantiti
cdv
n
siv
gag
sequenc
vector
genom
cours
infect
gag
insert
instabl
detect
vector
prototyp
provid
valuabl
inform
guid
vector
gene
insert
improv
stabil
foreign
gene
subsequ
vaccin
design
zhang
et
al
vero
cell
cultur
dulbecco
minim
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
gentamicin
cdv
propag
vero
cell
infecti
viru
quantifi
plaqu
assay
recombin
construct
use
procedur
describ
detail
elsewher
zhang
et
al
briefli
viru
live
attenu
vaccin
base
onderstepoort
strain
serial
passag
vero
cell
clonal
isol
deriv
multipl
round
plaqu
purif
genom
plaqu
isol
sequenc
molecular
clone
construct
genom
rna
synthesi
place
control
promot
bluescript
ii
sk
plasmid
stratagen
la
jolla
ca
usa
molecular
clone
modifi
insert
gag
gene
codonoptim
mammalian
cell
express
winston
et
al
first
genom
posit
cdv
genom
produc
cdna
fig
follow
gene
insert
overal
genom
length
follow
paramyxoviru
ruleofsix
kolakofski
et
al
rescu
cell
cotransfect
genom
plasmid
dna
support
plasmid
witko
et
al
express
cdv
structur
protein
n
p
f
h
l
dnadepend
rna
polymeras
use
calciumphosph
reagent
obtain
commerci
supplier
clontech
mountain
view
ca
usa
structur
protein
express
control
human
cmv
promot
pcineo
promega
madison
wi
usa
modifi
delet
rna
polymeras
promot
zhang
et
al
clonal
viru
isol
deriv
plaqu
purif
subsequ
expans
vero
cell
monolay
amplifi
larg
quantiti
viru
vero
cell
monolay
nunc
flask
thermo
scientif
waltham
usa
infect
h
dmem
contain
fb
multipl
infect
moi
medium
replac
fresh
dmem
contain
fb
cytopath
effect
evid
entir
monolay
cell
scrape
cultur
medium
cell
suspens
subject
two
freezethaw
cycl
suspens
clarifi
plaqueform
unit
pfu
determin
plaqu
assay
conduct
vero
cell
anim
care
procedur
took
place
state
univers
new
york
downstat
medic
center
conform
institut
anim
care
use
guidelin
vivo
studi
adher
regul
outlin
usda
anim
welfar
act
cfr
part
condit
specifi
guid
care
use
laboratori
anim
ilar
public
nation
academi
press
initi
studi
replic
time
cours
tissu
distribut
rcdv
ferret
inocul
pfu
empti
rcdv
vector
fig
administ
intranas
drop
three
ferret
per
day
sacrif
day
postinocul
dpi
anim
sedat
perfus
salin
minim
potenti
contamin
caus
viru
blood
mesenter
lymph
node
larg
intestin
high
densiti
peyer
patch
nasal
turbin
brain
brain
stem
olfactori
bulb
harvest
perfus
anim
studi
differ
rout
infect
evalu
weekold
ferret
inocul
intramuscular
intranas
intrarect
rout
pfu
fig
per
anim
anim
close
monitor
symptom
infect
follow
inocul
none
observ
three
ferret
intramuscular
intranas
inocul
sacrif
dpi
anim
inocul
intrarect
rout
sacrif
day
sinc
small
element
studi
includ
determin
cdv
could
deliv
rout
specimen
collect
includ
larg
intestin
high
densiti
peyer
patch
larg
intestin
low
densiti
peyer
patch
mesenter
lymph
node
rel
frequenc
mrna
transcript
genom
organ
vector
scheme
mrna
specif
rtqpcr
bind
site
qpcr
primer
probe
siv
gag
grna
mrna
assay
depict
transcript
attenu
result
gradient
mrna
synthesi
gag
messag
abund
n
messag
vector
rcdv
vector
vero
cell
adapt
onderstepoort
liveattenu
cdv
vaccin
galaxi
scheringplough
anim
health
corpor
omaha
ne
usa
obtain
commerci
sourc
vector
gag
gene
first
posit
genom
uniqu
uauaau
sequenc
common
cdv
n
siv
gag
genom
b
diagram
rt
step
use
singleplex
duplex
assay
synthes
cdna
mrna
cdvspecif
mrna
rtprimer
bind
uniqu
uauua
sequenc
common
cdv
n
siv
gag
mrna
transcript
adapt
sequenc
end
follow
oligodt
sequenc
termin
anchor
ataat
c
tag
cdna
gener
primer
pcr
amplifi
cdv
n
sivgag
forward
primer
label
probe
cdv
sequenc
tagrevers
primer
correspond
adapt
sequenc
describ
section
e
black
box
nt
indic
bind
site
qpcr
primer
probe
gag
specif
grna
rtqpcr
assay
nt
indic
amplicon
bind
site
qpcr
forward
primer
probe
use
gag
specif
mrna
rtqpcr
assay
fresh
ferret
tissu
specimen
weigh
suspend
c
phosphatebuff
salin
contain
sucros
phosphat
buffer
glutam
sucros
mm
k
hpo
mm
kh
po
mm
glutam
acid
pbsspbg
weightvolum
wv
homogen
use
omni
pdh
programm
digit
homogen
omni
kennesaw
ga
usa
stainless
steel
autoclav
probe
small
quantiti
nasal
turbin
materi
tissu
suspend
c
pbsspbg
homogen
use
omni
thqdigit
tissu
homogen
omni
kennesaw
ga
usa
plastic
autoclav
probe
make
wv
homogen
avoid
cross
contamin
among
tissu
specimen
tissu
homogen
separ
probe
seal
chamber
homogen
clarifi
centrifug
supernat
frozen
c
l
aliquot
subsequ
rna
extract
viru
quantif
plaqu
assay
primer
probe
set
specif
cdv
n
siv
gag
ferret
mitochondri
rrna
genbank
access
use
refer
gene
rg
target
design
use
primer
express
softwar
version
appli
biosystem
foster
ca
usa
cdv
n
gene
select
amplicon
essenti
gene
addit
insert
gag
first
posit
genom
anticip
reduc
n
mrna
synthesi
wertz
et
al
thu
interest
measur
rel
quantiti
n
mrna
express
recombin
viru
without
gag
gene
insert
fig
forward
revers
primer
operon
huntsvil
al
usa
oligonucleotid
probe
appli
biosystem
valencia
ca
usa
shown
tabl
cdvspecif
mrna
rtprimer
use
singleplex
duplex
assay
synthes
cdna
mrna
design
adapt
sequenc
end
cragg
et
al
simon
et
al
follow
oligodt
sequenc
termin
anchor
ataat
complimentari
uniqu
uauua
sequenc
common
cdv
n
siv
gag
mrna
transcript
tabl
fig
adapt
primer
design
overcom
signal
might
caus
grna
selfprim
also
improv
qpcr
specif
cragg
et
al
lanford
et
al
simon
et
al
order
discrimin
n
gag
sequenc
duplex
assay
cdv
n
probe
label
end
report
dye
vic
siv
gag
probe
fam
end
label
nonfluoresc
black
hole
quencher
minor
groov
binder
mgb
moieti
viral
nucleic
acid
extract
clarifi
homogen
tissu
infect
vero
cell
use
reagent
rneasi
mini
kit
qiagen
valencia
ca
usa
describ
previous
johnson
et
al
minor
modif
briefli
master
mix
includ
l
lysi
buffer
l
biorad
hercul
ca
usa
l
mgml
proteinas
k
qiagen
valencia
ca
usa
l
encapsid
enteroviru
armor
ar
rna
control
rna
copiesml
solut
asuragen
austin
tx
usa
mix
target
rna
sourc
materi
l
tissu
homogen
pellet
infect
vero
cell
neg
control
lysi
buffer
mix
aliquot
viru
use
inocul
posit
control
extract
rna
elut
column
l
rnasefre
water
subsequ
cdna
synthesi
detect
grna
neg
sens
perform
reaction
use
sensiscript
revers
transcriptas
kit
qiagen
valencia
ca
usa
describ
briefli
final
cdv
n
siv
gag
grna
singleplex
reaction
contain
l
total
rna
tissu
homogen
infect
vero
cell
extract
nm
cdv
n
forward
primer
siv
gag
genomeforward
primer
reagent
kit
detect
simultan
cdv
n
siv
gag
grna
duplex
assay
reagent
sampl
amount
remain
except
nm
cdv
n
forward
primer
siv
gag
genomeforward
primer
place
well
reaction
gener
standard
curv
contain
l
synthet
rna
molecul
dilut
serial
increment
span
cdv
n
siv
gag
amplicon
revers
transcript
perform
c
min
follow
heat
inactiv
revers
transcriptas
c
min
detect
cdv
n
siv
gag
mrna
transcript
singleplex
duplex
assay
final
reaction
contain
cdvspecif
mrna
rtprimer
substitut
cdv
n
forward
primer
siv
gag
genomeforward
primer
otherwis
reagent
condit
revers
transcript
rt
step
remain
ensur
excess
cdvspecif
mrna
rtprimer
carri
qpcr
step
exonucleas
usampl
new
england
ipswich
usa
ad
end
cdna
reaction
incub
c
min
follow
heat
activ
c
min
quantifi
grna
singleplex
duplex
qpcr
assay
carri
reagent
quantitect
multiplex
pcr
kit
qiagen
valencia
ca
usa
use
method
previous
describ
johnson
et
al
minor
modif
briefli
singleplex
assay
l
heatinactiv
rt
reaction
combin
pcr
mix
final
reaction
volum
contain
quantitect
multiplex
pcr
master
mix
nm
cdv
n
forward
revers
primer
nm
viclabel
probe
nm
siv
gag
genomeforward
revers
primer
nm
famlabel
probe
duplex
assay
primer
probe
set
templat
combin
reaction
singleplex
duplex
qpcr
assay
mrna
quantif
contain
reaction
reagent
cdv
n
forward
primer
probe
describ
grna
assay
gag
mrna
siv
gag
genomeforward
primer
probe
replac
siv
gag
mrnaforward
primer
probe
tabl
substitut
made
move
amplicon
closer
end
mrna
transcript
genomespecif
revers
primer
use
detect
cdv
n
siv
gag
also
replac
cdv
sequenc
tag
revers
primer
tabl
fig
amplif
detect
perform
stratagen
sequenc
detect
system
use
follow
condit
min
c
activ
hotstar
taq
dna
polymeras
follow
cycl
c
c
sampl
test
duplic
calcul
group
mean
valu
detect
limit
copiesg
tissu
assign
valu
copiesg
tissu
pcr
assay
use
analyz
gag
insert
integr
amplifi
kb
amplicon
includ
complet
gag
gene
posit
primer
shown
tabl
sampl
extract
describ
amplif
perform
use
onestep
rtpcr
kit
qiagen
valencia
ca
usa
final
reaction
contain
reagent
kit
nm
forward
revers
primer
g
tissu
extract
rna
rt
perform
c
min
initi
pcr
activ
step
c
min
pcr
perform
cycl
c
c
min
c
final
extens
c
min
rtpcr
product
analyz
agaros
gel
stain
ethidium
bromid
descript
synthet
rna
molecul
templat
ferret
housekeep
gene
armor
rna
control
two
genomesens
synthet
rna
oligonucleotid
synthes
span
cdv
n
siv
gag
amplicon
oligoribonucleotid
includ
two
extra
base
side
amplicon
pagepurifi
quantifi
trilink
san
diego
ca
usa
use
templat
develop
standard
curv
copi
number
synthet
oligonucleotid
calcul
previous
describ
control
sampletosampl
variat
especi
analyz
differ
solid
tissu
bustin
et
al
separ
singleplex
assay
base
ferret
rg
transcript
mitochondri
rrna
design
optim
rgspecif
primer
operon
huntsvil
al
usa
label
probe
appli
biosystem
valencia
ca
usa
sequenc
shown
tabl
sampl
normal
copi
rrna
report
grna
mrnag
tissu
data
shown
exogen
rnaseresist
encapsid
enteroviru
arrna
asuragen
austin
tx
usa
control
spike
known
concentr
lysi
buffer
rna
extract
determin
rna
extract
amplif
effici
paslosk
et
al
primer
operon
huntsvil
al
usa
ned
label
probe
appli
biosystem
valencia
ca
usa
tabl
specif
arrna
design
synthes
use
separ
rtqpcr
reaction
cycl
threshold
c
valu
observ
reliabl
extract
amplif
effici
data
shown
develop
attenu
cdv
live
vaccin
deliveri
vector
requir
studi
permiss
anim
host
assess
import
characterist
infect
like
extent
replic
dissemin
anim
host
genet
stabil
foreign
gene
addit
monitor
infect
vaccin
vector
administr
requir
sensit
specif
assay
perform
reliabl
use
assess
tissu
specimen
end
three
assay
develop
monitor
vector
replic
tissu
distribut
quantifi
grna
evalu
gene
express
detect
vectorencod
mrna
monitor
siv
gag
insert
stabil
replic
vivo
develop
singleplex
rtqpcr
assay
detect
cdv
n
siv
gag
gene
vector
grna
cdv
paramyxoviru
like
member
viru
famili
negativesens
singlestrand
nonseg
rna
genom
fig
studi
replic
gene
express
rcdv
rcdvsiv
gag
vector
primer
probe
set
design
detect
target
sequenc
cdv
n
essenti
cdv
gene
siv
gag
insert
specif
forward
primer
design
hybrid
negativesens
grna
rt
step
distinguish
grna
rna
speci
mrna
express
cdv
vector
individu
n
gag
singleplex
rtqpcr
reaction
condit
studi
achiev
optim
linear
sensit
use
purifi
oligoribonucleotid
templat
equival
negativesens
genom
strand
assay
conduct
serial
dilut
templat
rang
copi
data
plot
genom
copi
log
versu
c
result
show
n
gag
singleplex
assay
linear
rang
oligoribonucleotid
templat
copi
slope
curv
indic
pcr
effici
respect
supplement
fig
b
lower
limit
detect
synthet
rna
oligonucleotid
templat
copi
rna
templat
per
reaction
specif
singleplex
reaction
confirm
switch
target
templat
copi
observ
whether
cross
prime
amplif
would
occur
singleplex
assay
primerprob
set
detect
specif
target
data
shown
evalu
reproduc
individu
cdv
n
siv
gag
singleplex
rtqpcr
assay
serial
dilut
oligoribonucleotid
templat
rang
copi
test
repeatedli
intraassay
variat
assess
use
four
replic
templat
dilut
interassay
variat
evalu
test
templat
dilut
four
separ
run
oligoribonucleotid
standard
dilut
mean
standard
deviat
sd
coeffici
variat
cv
calcul
base
c
valu
cv
intraassay
interassay
variabl
cdv
n
singleplex
rtqpcr
assay
rang
respect
supplement
tabl
siv
gag
singleplex
rtqpcr
assay
cv
intraassay
interassay
variabl
rang
respect
supplement
tabl
taken
togeth
indic
assay
accur
capabl
gener
reproduc
result
optim
singleplex
reaction
primer
probe
use
duplex
rtqpcr
assay
detect
n
gag
simultan
duplex
assay
optim
test
use
equimolar
amount
n
gag
oligoribonucleotid
templat
rang
copi
number
per
reaction
linear
rang
amplif
effici
copi
number
detect
limit
c
valu
n
gag
assay
duplex
reaction
similar
observ
individu
singleplex
reaction
supplement
fig
result
indic
approxim
ntogag
c
valu
ratio
correspond
molar
quantiti
input
templat
result
also
indic
pair
amplicon
could
use
studi
genet
stabil
gag
insert
sinc
amplif
effici
similar
target
singlecopi
gene
cdv
vector
genom
confirm
whether
gag
insert
integr
could
studi
compar
ntogag
ratio
import
determin
respons
duplex
assay
proport
two
target
templat
vari
sinc
n
essenti
gene
chang
ntogag
ratio
replic
would
like
result
delet
gag
insert
sequenc
thu
duplex
rtqpcr
assay
must
abl
detect
reduc
quantiti
gag
grna
target
condit
n
grna
remain
abund
studi
conduct
duplex
reaction
n
oligoribonucleotid
templat
held
constant
copi
per
rtqpcr
reaction
titrat
serial
gag
templat
rang
copi
similar
experi
n
templat
held
copi
per
rtqpcr
reaction
titrat
serial
gag
templat
copi
sampl
test
duplic
duplex
rtqpcr
assay
result
summar
supplement
fig
n
oligoribonucleotid
templat
held
copi
per
reaction
n
c
valu
dark
bar
remain
steadi
quantiti
gag
templat
light
bar
vari
supplement
fig
similar
result
obtain
n
oligoribonucleotid
held
constant
lower
concentr
copi
supplement
fig
experi
measur
siv
gag
c
valu
accord
expect
c
valu
even
presenc
high
cdv
n
templat
background
copi
tabl
siv
gag
templat
could
detect
pcr
effici
respect
supplement
fig
b
importantli
result
demonstr
duplex
assay
could
reliabl
quantifi
copi
n
gag
sequenc
even
input
proport
vari
wide
rang
result
show
duplex
assay
provid
foundat
assay
studi
genet
stabil
vivo
replic
assay
develop
also
specif
detect
n
gag
mrna
assay
necessari
studi
durat
gene
express
cdv
vector
vaccin
anim
sever
studi
mev
indic
genom
persist
significantli
longer
period
time
origin
thought
lin
et
al
pan
et
al
pan
et
al
similar
outcom
also
observ
anim
infect
vsv
anoth
negativestrand
rna
viru
genom
persist
infect
cattl
rodent
johnson
et
al
simon
et
al
turner
et
al
thu
seem
negativestrand
rna
viru
grna
could
persist
tissu
signific
period
time
detect
shed
infecti
viru
end
therefor
import
assess
whether
persist
genom
express
detect
quantiti
mrna
purpos
rt
primer
design
would
anneal
polya
tail
specif
prime
cdna
synthesi
sever
cdv
mrna
primer
design
anchor
sequenc
ataat
fig
specif
sequenc
present
end
cdv
n
siv
gag
mrna
rt
primer
also
contain
adapt
sequenc
end
use
subsequ
pcr
amplif
singleplex
qpcr
tabl
evalu
cdvspecif
mrna
rtprimer
singleplex
duplex
rtqpcr
assay
c
separ
singleplex
reaction
cdv
n
sivgag
carri
differ
well
specif
primerprob
set
duplex
reaction
cdv
n
sivgag
done
well
contain
primerprob
set
specif
gene
carri
use
either
cdv
n
forward
primer
siv
gag
mrnaforward
primer
revers
primer
cdv
sequenc
tag
correspond
exactli
adapt
sequenc
fig
c
duplex
assay
done
forward
primer
revers
primer
reaction
well
confirm
primer
design
could
detect
n
gag
mrna
vero
cell
infect
total
rna
extract
subject
analysi
n
gag
singleplex
mrna
assay
ngag
duplex
mrna
assay
demonstr
assay
specif
positivesens
mrna
neg
control
reaction
perform
synthet
negativestrand
grna
templat
similar
c
valu
observ
singleplex
duplex
assay
indic
mrna
rtprimer
function
equal
well
assay
tabl
specif
cdv
n
siv
gag
mrna
signal
detect
high
level
copi
oligoribonucleotid
contain
negativestrand
grna
templat
empti
rcdv
vector
pfu
administ
ferret
intranas
drop
anim
sacrif
variou
time
postinfect
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
nasal
turbin
brain
brain
stem
olfactori
bulb
specimen
collect
process
isol
rna
analyz
twostep
singleplex
assay
specif
n
grna
mrna
dpi
grna
detect
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
genom
copi
increas
day
copiesg
subsequ
declin
day
fig
nasal
turbin
grna
peak
day
copiesg
copi
number
declin
day
fig
mrnaspecif
assay
use
n
mrna
copiesg
detect
day
nasal
turbin
day
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
rapid
appear
mrna
day
nasal
turbin
like
reflect
initi
burst
local
replic
follow
vaccin
administr
n
mrna
detect
later
day
lymphoid
tissu
peak
grna
viru
titer
also
peak
day
larg
intestin
rich
peyer
patch
mesenter
lymph
node
homogen
pfu
per
g
tissu
respect
data
shown
although
grna
detect
day
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
site
n
mrna
limit
detect
time
point
fig
undetect
n
mrna
quantiti
probabl
indic
earli
stage
infect
lymphoid
tissu
initi
subsequ
spread
viru
initi
foci
infect
upper
respiratori
track
mrna
undetect
nasal
turbin
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
sampl
indic
quantiti
activ
replic
declin
significantli
fig
observ
sign
ill
discomfort
ferret
inocul
empti
rcdv
vector
consist
observ
grna
mrna
viru
detect
brain
brainstem
olfactori
bulb
importantli
result
indic
even
larg
intranas
dose
pfu
infecti
viru
evid
invas
brain
attenu
recombin
strain
simultan
cdv
n
siv
gag
quantif
ferret
tissu
intranas
intramuscular
intrarect
administr
use
rtqpcr
duplex
assay
specif
grna
mrna
determin
ngag
duplex
assay
could
use
evalu
replic
tissu
distribut
gene
express
also
provid
reliabl
mean
monitor
gene
insert
stabil
tissu
region
larg
intestin
high
low
densiti
peyer
patch
mesenter
lymph
node
ferret
infect
prototyp
vector
analyz
two
group
ferret
infect
pfu
administ
intranas
drop
intramuscular
inject
tissu
harvest
anim
dpi
small
element
studi
vector
also
administ
intrarect
rout
third
smaller
group
anim
sacrif
day
determin
vector
could
deliv
rout
anim
immun
intranas
inocul
fig
result
show
grna
copi
detect
n
amplicon
highest
day
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
greater
copiesg
larg
intestin
section
low
densiti
peyer
patch
contain
less
genom
copi
time
point
indic
less
replic
occur
tissu
day
n
grna
declin
tissu
remain
detect
day
fig
gagspecif
grna
valu
compar
less
detect
tissu
day
fig
day
quantiti
gag
sequenc
declin
near
limit
detect
mesenter
lymph
node
undetect
larg
intestin
tissu
fig
day
result
show
expect
ratio
n
gag
grna
maintain
replic
vivo
also
ntogag
ratio
vari
duplex
grna
assay
indic
gag
insert
unstabl
rcdvsiv
gag
vector
n
gag
mrna
abund
also
analyz
tissu
use
duplex
rtqpcr
mrna
assay
anim
infect
intranas
inocul
known
rel
quantiti
mrna
express
negativesens
rna
virus
like
cdv
measl
viru
vsv
determin
transcript
gradient
gene
proxim
singl
genom
promot
fig
express
greater
quantiti
compar
gene
distal
promot
abraham
banerje
cattaneo
et
al
thu
high
level
siv
gag
mrna
somewhat
less
n
anticip
quantiti
n
mrna
peak
greater
copiesg
mesenter
lymph
node
larg
intestin
high
densiti
peyer
patch
day
low
detect
copiesg
larg
intestin
low
densiti
peyer
patch
fig
n
mrna
remain
detect
day
mesenter
lymph
node
limit
detect
larg
intestin
section
day
n
mrna
undetect
tissu
earli
infect
day
gag
mrna
abund
fig
n
tissu
expect
base
placement
highli
transcrib
region
cdv
genom
gag
mrna
quantiti
also
exceed
n
day
even
though
result
genom
qpcr
assay
describ
predict
gag
mrna
would
declin
rapidli
compar
n
see
section
taken
togeth
result
show
grna
persist
least
day
mrna
level
undetect
time
point
suggest
persist
genom
might
defect
transcript
replic
greatli
reduc
popul
cell
harbor
persist
cdv
grna
similar
pattern
genom
mrna
abund
observ
follow
intramuscular
inject
fig
anim
inocul
intranas
inocul
grna
copi
contain
n
sequenc
highest
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
copiesg
day
less
larg
intestin
tissu
low
densiti
peyer
patch
fig
grna
detect
n
amplicon
persist
slowli
decreas
day
tissu
compar
grna
copi
gag
decreas
approxim
day
detect
limit
day
mesenter
lymph
node
fig
siv
gag
grna
copi
detect
time
point
larg
intestin
low
peyer
patch
densiti
fig
ratio
greater
cdv
n
siv
gag
grna
copi
observ
larg
intestin
contain
high
amount
peyer
patch
mesenter
lymph
node
respect
consist
result
intranas
studi
indic
gag
insert
unstabl
replic
vivo
mrna
profil
obtain
follow
intramuscular
inject
also
similar
result
intranas
studi
cdv
n
mrna
detect
highest
level
larg
intestin
tissu
contain
higher
densiti
peyer
patch
mesenter
lymph
node
day
copiesg
becam
undetect
day
less
cdv
n
mrna
detect
larg
intestin
sampl
peyer
patch
less
abund
copiesg
day
undetect
later
time
point
fig
day
sivgag
mrna
copi
fig
time
abund
cdv
n
mrna
copi
fig
reflect
fact
increas
transcript
activ
gag
gene
posit
cdv
genom
fig
final
follow
intrarect
inocul
anim
infect
day
time
point
taken
similar
distribut
quantiti
grna
mrna
observ
seen
anim
inocul
intranas
drop
intramuscular
inject
indic
regardless
rout
inocul
vector
spread
lymphoid
tissu
amplifi
day
result
follow
intrarect
inocul
also
show
gag
mrna
abund
n
mrna
time
point
ntogag
grna
ratio
indic
gag
insert
instabl
data
shown
overal
analysi
genom
rna
indic
gag
insert
instabl
despit
mrna
detect
gag
mrna
signal
consist
greater
n
part
probabl
due
gag
gene
transcrib
activ
sinc
posit
genom
gag
mutant
emerg
gradual
cours
replic
vivo
subpopul
total
pool
replic
viru
furthermor
describ
gag
sequenc
delet
affect
grna
amplicon
target
sequenc
detect
mrna
amplicon
confirm
chang
ntogag
grna
ratio
indic
gag
insert
instabl
replic
ferret
tradit
gag
rtpcr
analyz
insert
integr
perform
gag
gene
isol
subset
day
day
sampl
subsequ
sequenc
instead
expect
kb
rtpcr
product
indic
intact
gag
gene
small
fragment
base
detect
fig
smaller
pcr
product
sequenc
result
show
delet
start
near
end
gag
code
sequenc
end
respect
negativesens
viral
genom
extend
gag
gene
first
nucleotid
genom
leav
nucleotid
fig
correspond
ctermin
code
sequenc
gag
sinc
delet
region
contain
anneal
site
nucleotid
fig
gagspecif
qpcr
primer
probe
grna
assay
chang
ntogag
grna
ratio
reflect
emerg
delet
mutant
fig
remain
nucleotid
auuau
sequenc
adjoin
poli
tail
maintain
anneal
site
siv
gag
forward
primer
probe
use
siv
gag
mrna
rtqpcr
assay
fig
thu
truncat
gag
sequenc
includ
gag
mrna
amplicon
contribut
high
mrnaspecif
signal
seen
day
follow
fig
im
fig
vaccin
sensit
specif
taqmanbas
duplex
rtqpcr
assay
develop
analyz
cdv
vector
replic
tissu
distribut
mrna
abund
foreign
gene
insert
stabil
infect
ferret
assay
work
effect
rna
isol
variou
tissu
homogen
provid
detect
copi
per
pcr
assay
assay
use
show
primari
site
cdv
vector
replic
infect
ferret
abdomin
caviti
lymphoid
tissu
importantli
cdv
grna
mrna
undetect
brain
tissu
taqmanbas
meli
et
al
wilk
et
al
singleplex
rtqpcr
assay
elia
et
al
fischer
et
al
scagliarini
et
al
describ
use
either
random
hexam
genespecif
primer
rt
step
mainli
purpos
monitor
cdv
outbreak
detect
cdv
rna
speci
specimen
assay
describ
report
differ
design
monitor
cours
infect
anim
model
studi
gag
gene
deliveri
cdvsiv
gag
vector
differenti
genom
mrna
speci
addit
mrna
analysi
primer
rtstep
design
includ
adapt
sequenc
sequenc
end
specif
siv
gag
cdv
n
mrna
significantli
reduc
background
cellular
rna
positivesens
vector
genom
rna
also
help
elimin
amplif
dna
caus
rna
selfprim
cragg
et
al
simon
et
al
recent
rtqpcr
assay
report
pawar
et
al
base
sybr
green
chemistri
detect
hemagglutinin
gene
sampl
infect
dog
assay
use
oligodt
primer
synthes
cdna
mrna
rt
step
rel
c
quantif
method
determin
fold
chang
cdv
gene
express
use
taqman
system
describ
permit
absolut
quantif
grna
mrna
also
multiplex
cdv
n
siv
gag
amplicon
recombin
cdv
investig
deliveri
vector
hiv
vaccin
potenti
specif
deliv
vaccin
immunogen
lymphoid
tissu
suscept
hiv
infect
zhang
et
al
previou
studi
show
virul
cdv
replic
ferret
gutassoci
lymphoid
tissu
galt
pillet
et
al
von
messl
et
al
work
extend
result
show
recombin
vector
base
attenu
vaccin
strain
also
target
galt
intranas
inocul
empti
rcdv
vector
abund
quantiti
grna
copiesg
detect
ferret
galt
day
persist
day
viral
mrna
similarli
detect
highest
day
genom
also
evid
day
larg
intestin
high
densiti
peyer
patch
mesenter
lymph
node
mrna
detect
earli
timepoint
lack
mrna
signal
day
probabl
due
earli
time
point
viru
replic
secondari
site
infect
cdv
n
grna
detect
day
ferret
tissu
mrna
day
fig
observ
result
might
indic
persist
genom
defect
transcript
activ
low
consist
lack
detect
infecti
viru
tissu
harvest
day
interestingli
result
number
studi
indic
negativestrand
rna
viru
genom
persist
consider
period
time
postinfect
genom
rna
measl
viru
lin
et
al
pan
et
al
pan
et
al
riddel
et
al
vesicular
stomat
viru
cooper
et
al
johnson
et
al
johnson
et
al
letchworth
et
al
simon
et
al
simon
et
al
turner
et
al
could
detect
tissu
well
shed
infecti
viru
end
cdv
vector
describ
report
develop
live
attenu
canin
vaccin
use
safe
effect
control
distemp
domest
dog
chappui
consist
canin
vaccin
safeti
record
recombin
vector
also
safe
use
ferret
permiss
speci
suscept
diseas
caus
natur
cdv
infect
importantli
nucleic
acid
viru
detect
brain
brain
stem
olfactori
bulb
follow
intranas
inocul
high
dose
pfu
indic
attenu
cdv
vector
replic
brain
conclus
also
consist
visual
observ
show
sign
ill
interestingli
duplex
assay
indic
siv
gag
signal
grna
decreas
significantli
compar
n
cours
infect
indic
part
gag
insert
delet
prototyp
vector
replic
vivo
tradit
rtpcr
genom
sequenc
use
subset
sampl
intranas
intramuscular
studi
confirm
gag
gene
unstabl
vector
variant
emerg
insert
delet
replic
vivo
delet
sequenc
includ
target
rtqpcr
amplicon
use
detect
gag
grna
assay
explain
reduct
signal
compar
n
amplicon
result
also
demonstr
duplex
qpcr
assay
gene
quantiti
ratio
could
use
effect
monitor
gene
insert
stabil
vivo
provid
valuabl
practic
data
guid
futur
vector
develop
specif
show
foreign
gene
altern
gene
optim
approach
need
gener
genet
stabl
negativestrand
rna
viru
vector
rabinovich
et
al
although
result
demonstr
feasibl
use
duplex
assay
sensit
monitor
genom
stabil
note
genom
delet
observ
rel
larg
result
excis
amplicon
target
thu
assay
improv
multipl
amplicon
develop
space
across
foreign
gene
insert
would
increas
probabl
detect
smaller
delet
observ
shift
ratio
gene
insert
genom
copi
ratio
nucleotid
sequenc
also
demonstr
gag
fragment
remain
kb
sequenc
delet
expect
genom
delet
mutant
conform
paramyxoviru
ruleofsix
kolakofski
et
al
state
total
number
nucleotid
genom
rna
must
multipl
replic
effici
truncat
gag
gene
contain
target
amplicon
sequenc
gag
mrnaspecif
rtqpcr
assay
abund
mrna
signal
observ
even
mutant
viru
emerg
becam
domin
speci
infect
ferret
consist
result
show
siv
gag
mrna
gener
abund
cdv
n
mrna
anticip
base
promoterproxim
placement
gag
gene
wertz
et
al
summari
result
present
show
duplex
rtqpcr
assay
describ
rapid
sensit
tool
analysi
cdv
vector
replic
vivo
use
quantifi
genom
mrna
speci
extract
varieti
tissu
furthermor
initi
studi
conduct
ferret
prototyp
cdvsiv
gag
vector
demonstr
qpcr
procedur
provid
foundat
develop
futur
assay
use
analyz
import
biolog
properti
new
replic
viral
vector
includ
replic
tissu
distribut
mrna
express
genet
stabil
